Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations

被引:45
作者
Woeber, KA [1 ]
机构
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
关键词
thyroxine; triiodothyronine; hypothyroidism; thyroiditis;
D O I
10.1007/BF03343972
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although the normal thyroid gland secretes both levothyroxine (L-T-4) and levotriiodothyronine (L-T-3), normalization of serum TSH with L-T-4-replacement therapy alone in hypothyroidism is generally believed to result in a normal serum L-T-3 and to reflect a euthyroid state. However several recent studies suggest that this may not be the case,. Accordingly, the relationship between serum free L-T-4 and free L-T-3 was examined in 20 normal individuals (group A) and in 53 patients with chronic autoimmune thyroiditis, 18 with normal TSH on no L-T-4-replacement (group B), and 35 with normal TSH on L-T-4-replacement therapy for hypothyroidism (group C). Data were analyzed by applying a one-way analysis of variance with correction for multiple comparisons. Serum TSH values were very similar among the 3 groups. In groups A and B, mean serum free T-4 and free T-3 were very similar. In group C, the mean free T-4 (16+/-2 pmol/l) was significantly higher than the values in groups A (14+/-1) and B (14+/-2) (p<0.001) and the mean free T-3 lower (4.0+/-0.5 pmol/l vs 4.2+/-0.5, NS and 4.4+/-0.5, p<0.02). Consequently, the mean molar ratio of free T-4 to free T-3 was significantly higher in group C than the ratios in groups A and B (p<0.0001), despite very similar TSH values. These findings indicate that in hypothyroid patients L-T-4-replacement, that is sufficient to maintain a normal serum TSH, is accompanied by a serum free T-4 that is higher than that in untreated euthyroid patients or normal individuals and may not result in an appropriately normal serum free T3 concentration. (C) 2002, Editrice Kurtis.
引用
收藏
页码:106 / 109
页数:4
相关论文
共 9 条
[1]   Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism [J].
Bunevicius, R ;
Kazanavicius, G ;
Zalinkevicius, R ;
Prange, AJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (06) :424-429
[2]   REPLACEMENT DOSE, METABOLISM, AND BIOAVAILABILITY OF LEVOTHYROXINE IN THE TREATMENT OF HYPOTHYROIDISM - ROLE OF TRIIODOTHYRONINE IN PITUITARY FEEDBACK IN HUMANS [J].
FISH, LH ;
SCHWARTZ, HL ;
CAVANAUGH, J ;
STEFFES, MW ;
BANTLE, JP ;
OPPENHEIMER, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (13) :764-770
[3]  
LARSEN PR, 1982, NEW ENGL J MED, V306, P23
[4]   TOTAL AND FREE THYROID-HORMONE CONCENTRATIONS IN PATIENTS RECEIVING MAINTENANCE REPLACEMENT TREATMENT WITH THYROXINE [J].
PEARCE, CJ ;
HIMSWORTH, RL .
BRITISH MEDICAL JOURNAL, 1984, 288 (6418) :693-695
[5]   THYROIDAL AND PERIPHERAL PRODUCTION OF 3,5,3'-TRIIODOTHYRONINE IN HUMANS BY MULTICOMPARTMENTAL ANALYSIS [J].
PILO, A ;
IERVASI, G ;
VITEK, F ;
FERDEGHINI, M ;
CAZZUOLA, F ;
BIANCHI, R .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 258 (04) :E715-E726
[6]   CHEMICAL HYPERTHYROIDISM - THE SIGNIFICANCE OF ELEVATED SERUM THYROXINE LEVELS IN L-THYROXINE TREATED INDIVIDUALS [J].
RENDELL, M ;
SALMON, D .
CLINICAL ENDOCRINOLOGY, 1985, 22 (06) :693-700
[7]  
StGermain DL, 1997, THYROID, V7, P655
[8]   REPLACEMENT DOSAGE OF L-THYROXINE IN HYPOTHYROIDISM - RE-EVALUATION [J].
STOCK, JM ;
SURKS, MI ;
OPPENHEIMER, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 1974, 290 (10) :529-533
[9]   Is excessive weight gain after ablative treatment of hyperthyroidism due to inadequate thyroid hormone therapy? [J].
Tigas, S ;
Idiculla, J ;
Beckett, G ;
Toft, A .
THYROID, 2000, 10 (12) :1107-1111